• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS / RESPIRONICS, INC. PHILIPS CPAP DREASTATION; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS / RESPIRONICS, INC. PHILIPS CPAP DREASTATION; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number 3935065
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Arrhythmia (1721); Asthma (1726); Inflammation (1932); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/01/2019
Event Type  Injury  
Event Description
Started using philips cpap dreamstation in 2008 then developed asthma in 2019, airway irritation and inflammation in 2019, irregular heartbeat around 2010, sinus infections in 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHILIPS CPAP DREASTATION
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS / RESPIRONICS, INC.
MDR Report Key13283894
MDR Text Key284045206
Report NumberMW5106716
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/18/2013
Device Model Number3935065
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/14/2022
Patient Sequence Number1
Treatment
CLONIDINE CL ; HYDROCHLOROTHIAZIDE ; SUDAFED ; VALSARTAN (325 MG); VERAPAMIL
Patient Outcome(s) Disability; Hospitalization; Required Intervention;
Patient Age54 YR
Patient SexMale
Patient Weight122 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-